Cocrystal Pharma, Inc. (COCP) is a biotechnology company headquartered in Bothell, Washington, specializing in the development of cutting-edge antiviral therapies for serious and chronic viral infections. The company employs advanced technologies and a robust research infrastructure to create innovative drug candidates aimed at addressing significant unmet medical needs within the antiviral sector. With a commitment to transforming antiviral treatment paradigms, Cocrystal Pharma seeks to enhance patient outcomes and expand healthcare solutions globally, positioning itself as a leader in this crucial therapeutic area. Show more

Location: 19805 NORTH CREEK PARKWAY, BOTHELL, WA, UNITED STATES, 98011, Bothell, WA, 98011, USA | Website: https://www.cocrystalpharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

13.24M

52 Wk Range

$0.90 - $2.34

Previous Close

$0.96

Open

$0.97

Volume

48,810

Day Range

$0.93 - $0.99

Enterprise Value

7.098M

Cash

7.729M

Avg Qtr Burn

-1.549M

Insider Ownership

32.48%

Institutional Own.

4.83%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Oral CC-42344 Details Influenza (pandemic & seasonal influenza A)	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CC-31244 (Pan-genotypic NS5B NNI) Details Hepatitis C	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CDI-988 Details Coronavirus, Norovirus	Phase 1b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Inhaled CC-42344 Details Influenza	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CDI-45205 Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.